Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 18 January, 2021. Please click to review the
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 18 January, 2021. Please click to review the
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 21 December, 2020. Please click to review the
Imagion Biosystems announces that it has received a total of $250,540.57 for the exercise of Options. Please click to review the full announcement at ASX.
Imagion Biosystems is pleased to provide its investors with its December 2020 Investor Newsletter. The newsletter details recent new company developments and activities including: Message from
Imagion Biosystems is pleased to announce that Monash Health has been established as the first clinical site and is ready to commence enrolment of patients
The document “Issue of Unlisted Performance Options under Equity Incentive Plan” was lodged with ASX on December 14, 2020. Please click to review the full
The document “Notification of Issue, Conversion of Payment up of Equity +Securities” was lodged with ASX on 14 December 2020. Please click to review the
Imagion Biosystems announces that Ms Jovanka Naumoska has resigned from her position as Company Secretary of Imagion Biosystems, effective today, 8 December 2020. Ms Naumoska
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 26 November, 2020. Please click to review the
Imagion Biosystems is pleased to announce the issue of the shares under the Placement (Placement) as announced to the market on 23 November 2020. The
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance
We have temporarily suspended our nanoparticle operations. Please revisit us in the future. We apologize for the inconvenience. Any questions, please email: info@imagionbio.com Dismiss